Insights

Strategic Licensing BMG Pharma operates a strong out-licensing model with a robust IP portfolio, presenting a clear sales opportunity to licensing partners and contract manufacturers seeking innovative dermatology, dermal aesthetics, oral care, osteoarthritis, and women’s health solutions.

Hyaluromimethic Advantage The Hyaluromimethic technology platform underpins a growing pipeline and marketed products, offering a differentiator for potential customers and co-development partners aiming to leverage modified sodium hyaluronate in biocompatible biomaterials.

Global Partner Network BMG already relies on a global partner network for distribution and commercialization, suggesting opportunities for new regional distributors, OEM collaborations, or strategic alliances to accelerate market reach and product launches.

Diversified Product Scope With products spanning prevention to treatment across dermatology, dermal aesthetics, oral care, and women’s health, there is potential to cross-sell to existing partners and expand into adjacent therapeutic and consumer healthcare segments.

Growth Signals Recent product launches and platform development news indicate momentum; combined with revenue in the low-to-mid seven figures and a modest funding base, there is room to pursue early-stage partnerships, R&D collaborations, or co-funding for new formulations.

Similar companies to BMG Pharma

BMG Pharma Tech Stack

BMG Pharma uses 8 technology products and services including Cloudflare Web Optimizations, WordPress, Cloudflare DNS, and more. Explore BMG Pharma's tech stack below.

  • Cloudflare Web Optimizations
    Analytics
  • Content Management System
  • Cloudflare DNS
    Domain Name Services
  • Marketing Automation
  • System Analytics & Monitoring
  • Bootstrap
    UI Frameworks
  • HTTP/3
    Web & Portal Technology

BMG Pharma's Email Address Formats

BMG Pharma uses at least 1 email format:
BMG Pharma Email FormatsExamplePercentage
First.Last@bmgpharma.comJohn.Doe@bmgpharma.com
100%

Frequently Asked Questions

What is BMG Pharma's official website and social media links?

Minus sign iconPlus sign icon
BMG Pharma's official website is bmgpharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does BMG Pharma generate?

Minus sign iconPlus sign icon
As of October 2026, BMG Pharma's annual revenue is estimated to be $1M - $10M.

What is BMG Pharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
BMG Pharma's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BMG Pharma have currently?

Minus sign iconPlus sign icon
As of October 2026, BMG Pharma has approximately 25 employees across 3 continents, including Europe, Asia and North America. Key team members include Chief Commercial Officer: P. P., Chief Scientific Officer: L. S. and Director Of Aesthetic Dermatology Business Unit: G. C. Explore BMG Pharma's employee directory with LeadIQ.

What industry does BMG Pharma belong to?

Minus sign iconPlus sign icon
BMG Pharma operates in the Biotechnology Research industry.

What technology does BMG Pharma use?

Minus sign iconPlus sign icon
BMG Pharma's tech stack includes Cloudflare Web Optimizations, WordPress, Cloudflare DNS, Google Workspace, HubSpot, Piwik, Bootstrap and HTTP/3.

What is BMG Pharma's email format?

Minus sign iconPlus sign icon
BMG Pharma's email format typically follows the pattern of First.Last@bmgpharma.com. Find more BMG Pharma email formats with LeadIQ.

How much funding has BMG Pharma raised to date?

Minus sign iconPlus sign icon
As of October 2026, BMG Pharma has raised $2.4M in funding. The last funding round occurred on Apr 29, 2021 for $2.4M.

When was BMG Pharma founded?

Minus sign iconPlus sign icon
BMG Pharma was founded in 2011.
BMG Pharma logo

BMG Pharma

Biotechnology ResearchLombardy, Italy11-50 Employees

BMG Pharma is an Italian biotechnology research company based in Milan, Lombardy. It develops and out-licenses patented products for dermatology, dermal aesthetics, oral care, osteoarthritis, and women's health, serving a B2B customer base of global partners. The company emphasizes an IP-led approach, with a development pipeline anchored by its Hyaluromimethic technology that modifies hyaluronic acid to create new biomaterial-based products. Its partners pursue registration, licensing, or co-development of innovative health solutions within these areas, leveraging both its marketed products and its ongoing programs. In 2021, BMG Pharma announced the SHLF injectable product platform, enabling broader development and potential global launches.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $2.4M

    BMG Pharma has raised a total of $2.4M of funding over 1 rounds. Their latest funding round was raised on Apr 29, 2021 in the amount of $2.4M as a Venture Round.

  • $1M - $10M

    BMG Pharma's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.